Brainstorm Cell Therapeutics Inc.Brainstorm Cell Therapeutics Inc.Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc.

No trades
See on Supercharts

Price target

6.000.000.00%
The 1 analyst offering 1 year price forecasts for BCLI have a max estimate of — and a min estimate of —.

Analyst rating

Based on 1 analyst giving stock ratings to BCLI in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


BCLI EPS for the last quarter is −0.52 USD despite the estimation of −0.38 USD. In the next quarter EPS is expected to reach −0.97 USD. Track more of Brainstorm Cell Therapeutics Inc. financials and stay on top of what is up with the company.
According to analysts, BCLI price target is 6.00 USD with a max estimate of 6.00 USD and a min estimate of 6.00 USD. Check if this forecast comes true in a year, meanwhile watch Brainstorm Cell Therapeutics Inc. stock price chart and keep track of the current situation with BCLI news and stock market news.